Nuzenio

Akebia Therapeutics Reports

Akebia Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Akebia Therapeutics, Inc. (AKBA) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 18:25:16 GMT Akebia Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 22:03:49 GMT Akebia Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:38:29 GMT Akebia Therapeutics (NASDAQ:AKBA) Releases Earnings Results - MarketBeatMarketBeat · Wed, 05 Aug 2026 21:25:55 GMT Akebia Therapeutics (NASDAQ: AKBA) posts Q2 loss with $155M cash - Stock TitanStock Titan · Wed, 05 Aug 2026 20:11:44 GMT Akebia begins trial for three rare kidney diseases; data expected in 2027 - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:00 GMT Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswireGlobeNewswire · Mon, 03 Aug 2026 20:05:00 GMT Two New Akebia Hires Get Stock Options With 4-Year Vesting - Stock TitanStock Titan · Mon, 03 Aug 2026 20:05:00 GMT

Timeline

Fri, 07 Aug 2026 18:25:16 GMTAkebia Therapeutics, Inc. (AKBA) stock price, news, quote and history - Yahoo Finance Singapore

Wed, 05 Aug 2026 22:03:49 GMTAkebia Therapeutics Q2 Earnings Call Highlights - TradingView

Wed, 05 Aug 2026 21:38:29 GMTAkebia Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView

Wed, 05 Aug 2026 21:25:55 GMTAkebia Therapeutics (NASDAQ:AKBA) Releases Earnings Results - MarketBeat

Wed, 05 Aug 2026 20:11:44 GMTAkebia Therapeutics (NASDAQ: AKBA) posts Q2 loss with $155M cash - Stock Titan

Wed, 05 Aug 2026 20:05:00 GMTAkebia begins trial for three rare kidney diseases; data expected in 2027 - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Akebia Therapeutics7 live mentions AKBA6 live mentions NASDAQ4 live mentions Inc3 live mentions Yahoo Finance Singapore3 live mentions Stock Titan Akebia3 live mentions Stock Titan Stock3 live mentions Titan3 live mentions Earnings Call Highlights2 live mentions TradingView Akebia Therapeutics2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Akebia Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.